{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:13:28Z","timestamp":1792098808475,"version":"4.4.0"},"reference-count":42,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"abstract":"<jats:p>Recent evidence suggests that treatment with mineralocorticoid receptor antagonist suppressed local inflammation in vascular tissues or cardiomyocytes; therefore, we examined the effect of spironolactone on glucose and lipid metabolism in a mouse model with diet-induced diabetes and nonalcoholic fatty liver disease. C57BL\/6 mice were fed either the control diet, 60% fat diet with 30% fructose water (HFFD), or HFFD with spironolactone for 8 wk. HFFD mice demonstrated apparent phenotypes of metabolic syndrome, including insulin resistance, hypertension, dyslipidemia, and fatty liver. Although treatment with spironolactone did not affect the increased calorie intake and body weight by HFFD, the increments of epididymal fat weight, blood pressure, serum triglyceride, free fatty acids, leptin, and total cholesterol levels were significantly suppressed. Elevation of blood glucose during glucose and insulin tolerance tests in HFFD mice was significantly lowered by spironolactone. Notably, increased glucose levels during pyruvate tolerance test in HFFD mice were almost completely ameliorated to control levels by the treatment. Staining with hematoxylin-eosin (HE) and Oil-red-O demonstrated marked accumulation of triglycerides in the centrilobular part of the hepatic lobule in HFFD mice, and these accumulations were effectively improved by spironolactone. Concomitantly HFFD feeding markedly up-regulated hepatic mRNA expression of proinflammatory cytokines (TNF\u03b1, IL-6, and monocyte chemoattractant protein-1), gluconeogenic gene phosphoenolpyruvate carboxykinase, transcription factor carbohydrate response element binding protein, and its downstream lipogenic enzymes, all of which were significantly suppressed by spironolactone. These results indicate that inhibition of mineralocorticoid receptor might be a beneficial therapeutic approach for diet-induced phenotypes of metabolic syndrome and fatty liver.<\/jats:p>","DOI":"10.1210\/en.2009-0869","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T17:38:56Z","timestamp":1271871536000},"page":"2040-2049","source":"Crossref","is-referenced-by-count":183,"title":["Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet"],"prefix":"10.1210","volume":"151","author":[{"given":"Tsutomu","family":"Wada","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kenmochi","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miyashita","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Sasaki","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ojima","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakiyo","family":"Sasahara","sequence":"first","affiliation":[{"name":"Departments of Pathology (Ma.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koya","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (D.K.), Kanazawa Medical University, Ishikawa 920-0293, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsuneki","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Sasaoka","sequence":"first","affiliation":[{"name":"Departments of Clinical Pharmacology (T.W., H.K., Y.M., Mo.S., M.O., H.T., T.S.), University of Toyama, Toyama 930-0194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,3,8]]},"reference":[{"key":"2020071612274417800_R1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism.","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"2020071612274417800_R2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome.","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocrinology"},{"key":"2020071612274417800_R3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance.","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"2020071612274417800_R4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance.","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"key":"2020071612274417800_R5","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3945\/ajcn.2008.25825D","article-title":"Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup.","volume":"88","author":"Stanhope","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"2020071612274417800_R6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/MOG.0b013e3282fbccf2","article-title":"Recent advances in nonalcoholic fatty liver disease.","volume":"24","author":"Greenfield","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"2020071612274417800_R7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2005.02.003","article-title":"The renin-angiotensin-aldosterone system, glucose metabolism and diabetes.","volume":"16","author":"Giacchetti","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2020071612274417800_R8","doi-asserted-by":"crossref","first-page":"35137","DOI":"10.1074\/jbc.M601320200","article-title":"Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.","volume":"281","author":"Wei","year":"2006","journal-title":"J Biol Chem"},{"key":"2020071612274417800_R9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jhep.2009.01.018","article-title":"Deletion of angiotensin II type I receptor reduces hepatic steatosis.","volume":"50","author":"Nabeshima","year":"2009","journal-title":"J Hepatol"},{"key":"2020071612274417800_R10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis.","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"2020071612274417800_R11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.","volume":"13","author":"Leopold","year":"2007","journal-title":"Nat Med"},{"key":"2020071612274417800_R12","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells.","volume":"16","author":"Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2020071612274417800_R13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1523-1755.2004.00913.x","article-title":"Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats.","volume":"66","author":"Fujisawa","year":"2004","journal-title":"Kidney Int"},{"key":"2020071612274417800_R14","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"2020071612274417800_R15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.107.689935","article-title":"Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community.","volume":"116","author":"Dhingra","year":"2007","journal-title":"Circulation"},{"key":"2020071612274417800_R16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease.","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"key":"2020071612274417800_R17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjp.0706098","article-title":"Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.","volume":"144","author":"Cassis","year":"2005","journal-title":"Br J Pharmacol"},{"key":"2020071612274417800_R18","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612274417800_R19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1210\/en.2006-0907","article-title":"Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of \u03b17 nicotinic receptors in isolated rat aortic smooth muscle cells.","volume":"148","author":"Wada","year":"2007","journal-title":"Endocrinology"},{"key":"2020071612274417800_R20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1210\/en.2007-0820","article-title":"Impact of transgenic overexpression of SH2-containing inositol 5\u2032-phosphatase 2 on glucose metabolism and insulin signaling in mice.","volume":"149","author":"Kagawa","year":"2008","journal-title":"Endocrinology"},{"key":"2020071612274417800_R21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.diabres.2008.05.007","article-title":"Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin.","volume":"81","author":"Wada","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"2020071612274417800_R22","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes.","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"2020071612274417800_R23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1291\/hypres.29.839","article-title":"Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.","volume":"29","author":"Grassi","year":"2006","journal-title":"Hypertens Res"},{"key":"2020071612274417800_R24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system.","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"2020071612274417800_R25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue.","volume":"112","author":"Wellen","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612274417800_R26","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease.","volume":"123","year":"2002","journal-title":"Gastroenterology"},{"key":"2020071612274417800_R27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2005.08.070","article-title":"Increased expression of PPAR\u03b3 in high fat diet-induced liver steatosis in mice.","volume":"336","author":"Inoue","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612274417800_R28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2006.06.008","article-title":"Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.","volume":"4","author":"Uyeda","year":"2006","journal-title":"Cell Metab"},{"key":"2020071612274417800_R29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1507\/endocrj.K07E-110","article-title":"ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.","volume":"55","author":"Iizuka","year":"2008","journal-title":"Endocr J"},{"key":"2020071612274417800_R30","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR\u03b1 and LXR\u03b2.","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev"},{"key":"2020071612274417800_R31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2004.11.043","article-title":"Hyperlipidemic effects of dietary saturated fats mediated through PGC-1\u03b2 coactivation of SREBP.","volume":"120","author":"Lin","year":"2005","journal-title":"Cell"},{"key":"2020071612274417800_R32","doi-asserted-by":"crossref","first-page":"E1180","DOI":"10.1152\/ajpendo.00471.2001","article-title":"Amelioration of high fructose-induced metabolic derangements by activation of PPAR\u03b1","volume":"282","author":"Nagai","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612274417800_R33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-2275(20)31661-8","article-title":"Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL\/6J mice.","volume":"42","author":"Murase","year":"2001","journal-title":"J Lipid Res"},{"key":"2020071612274417800_R34","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","article-title":"Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice.","volume":"50","author":"Toye","year":"2007","journal-title":"Diabetologia"},{"key":"2020071612274417800_R35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gene.2004.06.015","article-title":"Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.","volume":"340","author":"Kim","year":"2004","journal-title":"Gene"},{"key":"2020071612274417800_R36","doi-asserted-by":"crossref","first-page":"29031","DOI":"10.1074\/jbc.M309449200","article-title":"Single nucleotide polymorphism (\u2212468 Gly to A) at the promoter region of SREBP-1c associates with genetic defect of fructose-induced hepatic lipogenesis.","volume":"279","author":"Nagata","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071612274417800_R37","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1128\/MCB.20.7.2411-2422.2000","article-title":"A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen.","volume":"20","author":"Knutti","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2020071612274417800_R38","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-\u03b3, and proinflammatory adipokines.","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"2020071612274417800_R39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2020071612274417800_R40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.51.243","article-title":"Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade.","volume":"51","author":"Yamashita","year":"2004","journal-title":"Endocr J"},{"key":"2020071612274417800_R41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"2020071612274417800_R42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.","volume":"47","author":"Leclercq","year":"2007","journal-title":"J Hepatol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/5\/2040\/9008038\/endo2040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/151\/5\/2040\/9008038\/endo2040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T12:37:16Z","timestamp":1635251836000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/151\/5\/2040\/2456524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,8]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2009-0869","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,8]]}}}